Regenerative MedicineLab-Grown Dopamine Pathway Survives 6 Months Inside a Parkinson's Brain
Parkinson's disease destroys the dopamine-producing neurons that connect the substantia nigra to the striatum, and no current treatment rebuilds this pathway. Researchers at the University of Pennsylvania created tissue-engineered nigrostriatal pathways (TE-NSPs) by seeding human iPSC-derived dopaminergic neurons inside hydrogel microcolumns. These constructs grew axon tracts at 1 mm per day and mimicked the brain's natural dopamine circuit architecture. When implanted into rats with a Parkinson's-like lesion, the engineered tissue survived for six months, preserved its axon structure, extended fibers into the host striatum, and triggered measurable dopamine release at both three and six months post-implant. This is the first demonstration of chronic, long-distance brain pathway reconstruction using fully human-derived engineered microtissue, pointing toward a potentially transformative surgical therapy for Parkinson's disease.
